Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN
Status:
Completed
Trial end date:
2022-01-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of Acetyllevocarnitine Hydrochloride
Tablets compared with placebo after 24 weeks, in chinese patients with paresthesia caused by
Diabetic Peripheral Neuropathy (DPN).